Although the complete or partial loss of functional PML is a hallmark for various tumors [63,65], higher expression of PML has also been reported in tumors such as ovarian carcinoma and triple-negative breast cancer (TNBC) [23,73]. The gene discussed is PML; the disease is ovarian carcinoma.